Subject
Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy
Reference61 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022
2. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial;Durie;Lancet,2017
3. Kumar SK, Anderson LD, Baljevic M, et al. NCCN Guidelines Version 4.2022. 2021. Available from: www.nccn.org/patents. Accessed March 2nd, 2022.
4. IMWG consensus on risk stratification in multiple myeloma;Chng;Leukemia,2014
5. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma;Attal;N Engl J Med,2017